Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Investing Activities (2016 - 2025)

PAVmed has reported Cash from Investing Activities over the past 5 years, most recently at -$14000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 250.0% year-over-year to -$14000.0; the TTM value through Dec 2025 reached -$31000.0, up 86.64%, while the annual FY2025 figure was -$31000.0, 99.81% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$14000.0 at PAVmed, down from -$3000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $974000.0 in Q1 2023 and troughed at -$3.4 million in Q4 2021.
  • A 5-year average of -$409368.4 and a median of -$36000.0 in 2021 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 1494.44% in 2022 and later skyrocketed 269.69% in 2023.
  • Year by year, Cash from Investing Activities stood at -$3.4 million in 2021, then soared by 91.18% to -$298000.0 in 2022, then skyrocketed by 38.59% to -$183000.0 in 2023, then skyrocketed by 97.81% to -$4000.0 in 2024, then crashed by 250.0% to -$14000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for PAVM at -$14000.0 in Q4 2025, -$3000.0 in Q3 2025, and -$8000.0 in Q2 2025.